Tammi

Tam is currently Postdoctoral Fellow in Cancer Genetics at Roswell Park Cancer Center, where she is investigating elements of cellular replication thought to be critical to cancer development.

Telomeres are specialized, highly repeated DNA sequences at the ends of chromosomes which allow them to successfully complete replication and prevent chromosome breakage. In the life of a normal cell, the numbers of repeats decrease at each replication cycle until a critical length is reached, whereafter the cell goes into senescence. Tumor cells overcome this limitation by producing an RNA/protein enzyme, telomerase, which adds new repeats to the ends of chromosomes. Telomerase appears to be expressed almost exclusively in tumor cells and not in normal cells. Thus, telomerase represents a target for anti-tumor therapy. We have shown that certain siRNA segments inhibit cell growth of breast cancer cells in vitro.  Normal cells were unaffected by the treatment. The mechanism of cell death was by apoptosis and microchip scanning experiments are now underway to investigate the pathways involved in the apopototic death.

View Tammi's Curriculum Vitae here

Judd

Judd is Director, Sales Engineering for Univisions, where he oversees design and development of Communications, Broadcast, and Video Networks.

Our current focus is on ultra-high bandwidth systems for transporting video and audio over Local and Wide-Area Networks. Applications for this technology are primarily in Medical, Military, and Educational video-on-demand systems, wherein users can access centrally stored and secured content at full Broadcast quality from anywhere in the world.

Univisions continues to expand its partnerships with IBM Global Services and Verizon Communications to design, build, and deploy Command & Control Systems, Network Operations Centers, and Secure Videoconferencing networks throughout the Northeast U.S.

View Judd's Resume here